BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 24, 2006
View Archived Issues
Enrollment completed in second phase III study of Sanctura XR
Read More
Novelos files IND for NOV-205 for chronic hepatitis C
Read More
Ono and Santen enter ophthalmic licensing agreement for ONO-6126
Read More
New phase Ib/II trial studies PXD-101 with Velcade in multiple myeloma
Read More
Pixantrone combination regimen shown effective in relapsed aggressive NHL
Read More
Second phase III study begins for Viprinex in acute ischemic stroke
Read More
Orphan drug designation for HD-02 for Huntington's disease
Read More
Arius licenses antibody to Genentech
Read More
Ceragenix compounds inhibit angiogenesis in in vitro tests
Read More
pSivida offers progress report
Read More
GammaCan holds pre-IND meeting with FDA for VitiGam
Read More
VistaGen and Cato BioVentures sign strategic agreement for CNS products
Read More
Astellas licenses antihuman osteopontin antibodies
Read More
Encouraging preclinical results for oral NNZ-2566
Read More
Chemoprotective effects of DMU-135, a new anticancer prodrug
Read More
Novel therapeutic agents for respiratory disorders disclosed in recent patents
Read More
Novel 5-HT7 receptor antagonists prepared and tested at Esteve
Read More
New monoclonal TCR technology for cancer-specific immunotargeting
Read More
Flovent HFA approved for asthmatic children aged 4-11 years
Read More
BLA submission for FluLaval
Read More
Taxotere approved for advanced stomach cancer
Read More
New P2X7 receptor antagonists emerge from Abbott R&D
Read More
Novel immunomodulator holds promise for treatment of allergic inflammation
Read More
Promising preclinical results with novel oral insulin developed by Terumo
Read More
Cytotoxic treatment could be used to fight H5N1 infection
Read More
Glycan microarray analysis reveals possible route for avian influenza virus to adapt to humans
Read More